Objective
RNA is an essential element in the flow of genetic information in the cell. Recent development of genome-wide techniques reveal multiple novel RNA transcripts, mostly non-coding (nc) for protein. Their significance for the cell is still poorly understood and at first they were considered as “noise”. During the recent decade research has revealed growing evidence for the importance of ncRNAs in cell development and disease. Further elaboration of their functions remains a pressing need in the field. To address this gap in knowledge we will focus on clarifying their regulation. One of key processes modulating levels of RNA in the cell is degradation. Xrn1 is a highly conserved 5’-3’ exoribonuclease that plays an important role in RNA decay. At the Institut Curie the Morillon’s group has discovered that a class of long non-coding (lnc)RNAs is highly sensitive to Xrn1-decay in yeast. The XRN1 sequence is well-conserved from yeast to human, but very little is known about human (h)Xrn1 targets other than mRNAs. Recent studies have revealed involvement of human lncRNAs in cancerogenesis or viral infection. Moreover, studies of Hepatitis C virus (HCV) have shown that viral infection change ncRNA levels. Others have reported that viral structured (sf)RNA can inhibit hXrn1. But how this sfRNA affect ncRNA-om was not yet determined. Importantly, Xrn1 can localize to cytoplasmic foci called P-bodies which are dynamic reservoirs of multiple RNAs and proteins involved in processes such RNA silencing or RNA decay. It has been demonstrated that P-bodies are altered in multiple human diseases and upon viral infection. There are three objectives for this project: 1) identifying novel members of the hXrn1-sensitive coding and noncoding transcriptome, 2) understanding, on a genome-wide scale, how the impairment of hXrn1 by viral sfRNA can change ncRNA stability, as well as their potential role in infection 3) defining the effect of hXrn1 impairment on P-body formation and composition.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences microbiology virology
- medical and health sciences health sciences infectious diseases RNA viruses hepatitis C
- natural sciences biological sciences biochemistry biomolecules proteins
- natural sciences biological sciences genetics RNA transcriptomes
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75231 Paris
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.